In the News Gambro BCT announces research partnership with Walter Reed Army Institute of Research for application of Pathogen Eradication Technology to malaria.
Research seeks to eliminate malaria from blood supply.
Kevin Simpson, new Vice President of Gambro BCT and General Manager of its Pathogen Eradication Technology Project. Gambro AB, a leading international medical technology and healthcare company, today announced that Gambro BCT has appointed Kevin Simpson as Vice President, Gambro BCT, and General Manager of its Pathogen Eradication Technology project. In this new role, Mr. Simpson will lead the worldwide Pathogen Eradication Technology project development and commercialization. He will join the company on June 11, 2001. Reuters interviews S ren Mellstig , the President of the Gambro Healthcare Company, who wants the company to invest, to an increasing extent, in small research projects, closely linked to the core activities of the business areas.